SO
Sobi
SOBI.ST·OMXStockholm SEFounded 20011,700 employees
Large CapbiotechPublicRare DiseaseHematology
Platform: Rare Bio
Market Cap
$10B
All Drugs
5
Clinical Trials
7
Failed / Terminated
2
FDA Approved
0
Stock Price & Catalysts (SOBI.ST)
Loading SOBI.ST stock data...
Drug Pipeline (5 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Lisosotorasib | SOB-2014 | Phase 2/3 | 1 | CDK4/6 | MCCPV | ||
| SOB-2861 | SOB-2861 | Phase 2 | 2 | RET | CKD | ||
| Talatuximab | SOB-5438 | Phase 1/2 | 1 | CD19 | PsA | ||
| Miriderotide | SOB-7855 | NDA/BLA | 2 | MDM2 | SchizophreniaRett | ||
| Polasertib | SOB-2847 | Phase 1 | 1 | RET | NSCLCRB |
SEC Filings & Financial Documents
SEC filings are not available for OMX-listed companies.
Sobi trades on OMX (SE). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (6)